Related Experiment Video
Updated: May 5, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Epigenetic therapy in human choriocarcinoma
Noriyuki Takai1, Hisashi Narahara
1Department of Obstetrics and Gynecology, Oita University Faculty of Medicine, Oita, Japan. takai@oita-u.ac.jp.
Histone deacetylase inhibitors (HDACIs) show promise for treating choriocarcinoma by targeting epigenetic alterations. Preclinical studies indicate HDACIs can inhibit tumor cell growth, induce apoptosis, and affect malignant gene expression.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Epigenetic alterations are implicated in choriocarcinoma development, potentially through tumor suppressor gene repression.
- Histone deacetylase (HDAC) enzymes play a role in these epigenetic changes.
- Targeting HDACs offers a potential therapeutic strategy for choriocarcinoma.
Purpose of the Study:
- To review the biological and therapeutic effects of HDAC inhibitors (HDACIs) in choriocarcinoma.
- To focus on preclinical evidence supporting HDACIs as a treatment for choriocarcinoma.
Main Methods:
- Review of preclinical studies investigating HDAC inhibitors in choriocarcinoma models.
- Analysis of the impact of HDACIs on choriocarcinoma cell lines.
Main Results:
- HDACIs demonstrated inhibition of cell growth in choriocarcinoma cell lines.
- HDACIs induced cell cycle arrest and apoptosis.
- HDACIs modulated the expression of genes associated with the malignant phenotype.
Conclusions:
- HDACIs represent an attractive therapeutic approach for choriocarcinoma due to their effects on epigenetic regulation.
- Preclinical data support the potential of HDACIs in managing choriocarcinoma.
Related Concept Videos
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Epigenetic Regulation
X-chromosome...
Tumor Immunotherapy
Gene Therapy
Gene Therapy

